KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $37.1 billion.

  • Novartis Ag's Total Non-Current Liabilities rose 2614.52% to $37.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $37.1 billion, marking a year-over-year increase of 2614.52%. This contributed to the annual value of $37.1 billion for FY2025, which is 2614.52% up from last year.
  • According to the latest figures from Q4 2025, Novartis Ag's Total Non-Current Liabilities is $37.1 billion, which was up 2614.52% from $30.5 billion recorded in Q3 2025.
  • Novartis Ag's Total Non-Current Liabilities' 5-year high stood at $41.0 billion during Q1 2021, with a 5-year trough of $25.3 billion in Q1 2024.
  • Its 5-year average for Total Non-Current Liabilities is $31.3 billion, with a median of $30.2 billion in 2025.
  • As far as peak fluctuations go, Novartis Ag's Total Non-Current Liabilities crashed by 2054.71% in 2021, and later surged by 2614.52% in 2025.
  • Novartis Ag's Total Non-Current Liabilities (Quarter) stood at $33.8 billion in 2021, then fell by 13.0% to $29.4 billion in 2022, then decreased by 8.75% to $26.8 billion in 2023, then increased by 9.79% to $29.4 billion in 2024, then grew by 26.15% to $37.1 billion in 2025.
  • Its last three reported values are $37.1 billion in Q4 2025, $30.5 billion for Q3 2025, and $30.6 billion during Q2 2025.